Clinical Trial Update: VELCADE,Rituximab,Cyclophosphamide and Decadron [Phase 2]

View source ↗

Summary

Phase 2 trial update for Velcade in combination with Rituximab, Cyclophosphamide, and Decadron in B-cell non-Hodgkin lymphoma, with terminated status and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• Velcade (bortezomib)

Snippet

Sponsor: Oncology Specialists, S.C. | Conditions: Lymphoma, Non-Hodgkin, Lymphoma, B-Cell | Phase 2 | Status: TERMINATED | Results posted: 2013-09-27